Literature DB >> 19246720

FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis.

Prabhat K Sharma1, Pradip K Saha, Amar Singh, Surendra K Sharma, Balaram Ghosh, Dipendra K Mitra.   

Abstract

RATIONALE: The inadequacy of effector T-cell response in containment of tubercle bacilli is believed to result in the development of disseminated forms of tuberculosis (TB), such as miliary tuberculosis (MTB). Regulatory T cells (Treg) plausibly play a critical role in the immunopathogenesis of disseminated TB by suppression of effector immune response against Mycobacterium tuberculosis at the pathologic site(s). To understand the role of Treg cells in disseminated tuberculosis, we studied the frequency and function of Treg cells derived from the local disease site specimens (LDSS) of patients with TB pleural effusion and MTB as clinical models of contained and disseminated forms of disease, respectively.
OBJECTIVES: To (1) enumerate the frequency of Treg cells in bronchoalveolar lavage (BAL) fluid of patients with MTB and compare with that of peripheral blood, (2) study the role of Treg cells in suppression of local T-cell response, and (3) study the selective recruitment of Treg cells at the local disease site(s).
METHODS: Flow cytometry, reverse transcriptase polymerase chain reaction, and 3-(4,5-dimethylthythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-based cell proliferation assay.
MEASUREMENTS AND MAIN RESULTS: Frequency of Treg cells (CD4(+)CD25(+)FoxP3(+)) was significantly higher in LDSS in MTB along with higher levels of FoxP3 mRNA. Importantly, FoxP3(+) Treg cells obtained from the BAL of patients with MTB predominantly produced IL-10 and could suppress the autologous T-cell proliferation in response to M. tuberculosis antigen.
CONCLUSIONS: Our results highlight the importance of Treg cells in suppression of effector immune response and their influence on bacillary dissemination, disease manifestation, and severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246720     DOI: 10.1164/rccm.200804-529OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  51 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 3.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

4.  IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB.

Authors:  Crystal Y Chen; Dan Huang; Shuyu Yao; Lisa Halliday; Gucheng Zeng; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

5.  Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.

Authors:  Kun Taek Park; Andrew J Allen; John P Bannantine; Keun Seok Seo; Mary J Hamilton; Gaber S Abdellrazeq; Heba M Rihan; Amanda Grimm; William C Davis
Journal:  Vaccine       Date:  2011-05-10       Impact factor: 3.641

Review 6.  Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue.

Authors:  William C Davis; Sally A Madsen-Bouterse
Journal:  Vet Immunol Immunopathol       Date:  2011-12-14       Impact factor: 2.046

7.  Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.

Authors:  A Singh; A Mohan; A B Dey; D K Mitra
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

8.  Tuberculous pleurisy drives marked effector responses of γδ, CD4+, and CD8+ T cell subpopulations in humans.

Authors:  Jincheng Zeng; Zeqing Song; Xiaozhen Cai; Su Huang; Wandang Wang; Yanfen Zhu; Yinan Huang; Bin Kong; Wenyu Xiang; Dongzi Lin; Ganbin Liu; Junai Zhang; Crystal Y Chen; Hongbo Shen; Dan Huang; Ling Shen; Lailong Yi; Junfa Xu; Zheng W Chen
Journal:  J Leukoc Biol       Date:  2015-07-08       Impact factor: 4.962

9.  Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Authors:  Steven G Smith; Maeve K Lalor; Patricia Gorak-Stolinska; Rose Blitz; Natalie E R Beveridge; Andrew Worth; Helen McShane; Hazel M Dockrell
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

10.  Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.